Mind Medicine Inc (MNMD NASDAQ) stock market data APIs
$12.2552
0.31(2.5%)
as of November 12, 2025
Try our APIs with
free plan!
Mind Medicine Inc Financial Data Overview
Price chart is built with
Anychart
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Prev. Close
12.2552
Open
12.5625
High
13.1485
Low
12.168
52 wk Range
4.7-14.43
Market Cap
1 196 M
Shares Outstanding
97 219 K
EPS
-0.78
Beta
2.793
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Mind Medicine Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mind Medicine Inc data using free add-ons & libraries
Get Mind Medicine Inc Fundamental Data
Mind Medicine Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -151 672 752
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -0.39
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mind Medicine Inc News
New
MindMed outlines three pivotal Phase III data readouts for 2026 as enrollment accelerates and $242.8M financing strengthens balance sheet
Earnings Call Insights: Mind Medicine (MindMed) Inc. (MNMD) Q3 2025 MANAGEMENT VIEW * CEO Robert Barrow stated, "We delivered another solid quarter, advancing our clinical programs and continuing ...
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: * Block (XYZ [https://seekingalpha.com/symbol/XYZ]) * The Trade Desk (TTD [https://seekingalpha.com/symbol/TTD]) * Airbnb (ABNB [http...
The Math Shows FHLC Can Go To $79
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, an...
IRON Gets Stronger, MNMD Sends A Soothing Signal To Investors, Will Christmas Come Early For NKTR?
(RTTNews) - "Returns matter a lot. It's our capital," said Abigail Johnson, chief executive of Fidelity Investments - a powerful reminder that successful investing isn't just about owning stocks, but ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
